We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBRE icon
126
CBRE Group
CBRE
$43.1B
$24.4M 0.2%
405,219
– –
CLX icon
127
Clorox
CLX
$12.1B
$24.3M 0.2%
125,181
– –
GNRC icon
128
Generac Holdings
GNRC
$11.5B
$23.9M 0.2%
109,525
-9
-0% -$2.65K
UPS icon
129
United Parcel Service
UPS
$89.7B
$23.8M 0.2%
146,937
– –
SNPS icon
130
Synopsys
SNPS
$73.5B
$23.7M 0.2%
95,047
-2
-0% -$508
ARVN icon
131
Arvinas
ARVN
$529M
$23.6M 0.2%
289,414
– –
FATE icon
132
Fate Therapeutics
FATE
$270M
$23.6M 0.2%
270,107
-4
-0% -$383
EL icon
133
Estee Lauder
EL
$30.7B
$23.5M 0.2%
91,770
– –
VRNS icon
134
Varonis Systems
VRNS
$5.13B
$23.3M 0.19%
148,122
-296,244
-67% -$17.6M
NFLX icon
135
Netflix
NFLX
$301B
$23.2M 0.19%
445,770
– –
EXAS
136
DELISTED
Exact Sciences
EXAS
$22.4M 0.19%
175,874
-2
-0% -$274
TX icon
137
Ternium
TX
$9.68B
$22.3M 0.19%
798,200
– –
AMBA icon
138
Ambarella
AMBA
$3.03B
$22.2M 0.19%
252,262
– –
BBY icon
139
Best Buy
BBY
$18.9B
$21.9M 0.18%
228,894
– –
WORK
140
DELISTED
Slack Technologies, Inc.
WORK
$21.8M 0.18%
536,463
– –
XNCR icon
141
Xencor
XNCR
$1.48B
$21.6M 0.18%
515,412
-2
-0% -$95
ELV icon
142
Elevance Health
ELV
$83.7B
$20.9M 0.17%
67,672
– –
KOD icon
143
Kodiak Sciences
KOD
$2.52B
$20.6M 0.17%
145,669
– –
NEE icon
144
NextEra Energy
NEE
$186B
$20.5M 0.17%
276,806
-18
-0% -$1.41K
ALNY icon
145
Alnylam Pharmaceuticals
ALNY
$38.5B
$20.3M 0.17%
162,558
– –
PLD icon
146
Prologis
PLD
$137B
$19.4M 0.16%
202,866
– –
CI icon
147
Cigna
CI
$79.6B
$19M 0.16%
95,073
– –
MMM icon
148
3M
MMM
$94.1B
$18.3M 0.15%
130,204
– –
CERN
149
DELISTED
Cerner Corp
CERN
$18.2M 0.15%
236,156
– –
RETA
150
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$18M 0.15%
151,707
– –
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.